Ongoing studies of elranatamab in frail patients & with DaraPomDex: MagnetisMM-3 & MagnetisMM-5
4 months ago
[{"url":"https://i.ytimg.com/vi/8xt3yl6omus/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLDneXRNCBujdCzzfVOg0zRd-wSeSw","width":360,"height":202},{"url":"https://i.ytimg.com/vi/8xt3yl6omus/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLDIYk94j4hC_wBoJDO2e94SjYsTYQ","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/8xt3yl6omus/mqdefault_6s.webp?du=3000&sqp=COn2sKkG&rs=AOn4CLAiU9yLkljnWC0Z4DFAuy8kIEh05w","width":320,"height":180}
[{"text":"Xavier Leleu, MD, PhD, Poitiers University Hospital, Poitiers, France, gives an overview of two posters on elranatamab from this\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Ongoing studies of elranatamab in frail patients & with DaraPomDex: MagnetisMM-3 & MagnetisMM-5 by VJHemOnc \u2013 Video Journal of Hematological Oncology 100 views 4 months ago 6 minutes, 14 seconds","duration":"6 minutes, 14 seconds"}